Form 4 for RCEL AVITA Medical, Inc.

Accepted 2021-09-21 00:00:00 ET · period of report 2021-09-20 · accession 0001209191-21-057037 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2021-09-21	2021-09-20	RCEL	Crowe Suzanne	Dir	P - Purchase	$17.08	+1,066	4,112	+35%	+$18.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-09-20	P	A	1,066	$17.08	4,112	D	—	—	(F1) Reflects 5,330 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of the Issuer's common stock and have all the rights and privileges of common stock. (F2) The purchase price was converted from A$4.72, using the exchange rate as in effect on the date of the transaction, and reflects the 5:1 consolidation ratio applied in converting CDIs to shares of the Issuer's common stock. (F3) The Reporting Person holds 20,560 CDIs, which translate into the 4,112 shares of common stock set forth above.